Drug Discov Ther. 2023;17(5):363-364. (DOI: 10.5582/ddt.2023.01063)

EQUIBIND: A geometric deep learning-based protein-ligand binding prediction method

Li YZ, Li L, Wang S, Tang XW


Structure-based virtual screening plays a critical role in drug discovery. However, numerous docking programs, such as AutoDock Vina and Glide, are time-consuming due to the necessity of generating numerous molecular conformations and executing steps like scoring, ranking, and refinement for the ligand-receptor complexes. Consequently, achieving rapid and reliable virtual screening remains a noteworthy challenge. Recently, a team of researchers from Massachusetts Institute of Technology, led by Stärk et al., developed an SE(3)-equivariant geometric deep learning based protein-ligand binding prediction approach, EQUIBIND. In comparison to conventional docking methods, EQUIBIND has the capacity to predict the binding modes of small molecules with target proteins rapidly and precisely. It presents an innovative resolution for high-throughput screening of drug-like compounds.

KEYWORDS: EQUIBIND, deep learning, virtual screening, protein-ligand binding prediction

Full Text: